反応式
[OH-].[Na+].[CH3:3][O:4][C:5]1[CH:12]=[CH:11][C:8]([CH2:9][SH:10])=[CH:7][CH:6]=1.[C:13]([O:17][C:18]([N:20]1[CH2:24][C@H:23](OS(C)(=O)=O)[CH2:22][C@H:21]1[C:30](=[O:34])[N:31]([CH3:33])[CH3:32])=[O:19])([CH3:16])([CH3:15])[CH3:14]>CN(C)C=O>[C:13]([O:17][C:18]([N:20]1[CH2:24][C@@H:23]([S:10][CH2:9][C:8]2[CH:11]=[CH:12][C:5]([O:4][CH3:3])=[CH:6][CH:7]=2)[CH2:22][C@H:21]1[C:30](=[O:34])[N:31]([CH3:32])[CH3:33])=[O:19])([CH3:16])([CH3:15])[CH3:14]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
151 mg of sodium hydroxide (as a 55% w/w dispersion in mineral oil) were added, whilst ice-cooling, to a solution of 532 mg of 4-methoxybenzyl mercaptan dissolved in 10 ml of dry dimethylformamide. The mixture was then stirred at room temperature for 30 minutes, after which 1.05 g of (2S, 4R)-1-(t-butoxycarbonyl)-2-(N,N-dimethylcarbamoyl)-4-methanesulfonyloxypyrrolidine [prepared as described in step (2) above] was added. The reaction mixture was then stirred at room temperature for 30 minutes and then at 40° C. for 6 hours. At the end of this time, it was treated and purified according to the procedure described in Preparation 1-(4), to afford 385 mg of the title compound as an oil.
後処理
- stirringThe reaction mixture was then stirred at room temperature for 30 minutes
- waitat 40° C. for 6 hours
- additionAt the end of this time, it was treated
- custompurified
- customdescribed in Preparation 1-(4)
出典と根拠
- ORDレコード
- ord-daab5ee4b89e4b57bb5dd1d29f4fa7c5
- 出典データセット
- uspto-grants-1993_09
- 特許番号
- US05242914
関連ノート
読み込み中…